KBIO LABS Inc. (KOSDAQ:038530)

KBIO LABS Revenue

KBIO LABS had revenue of 12.24B KRW in the quarter ending June 30, 2026, with 22.25% growth. This brings the company's total for the last twelve months to 92.08B, up 57.61% year-over-year. In the year 2025, KBIO LABS had annual revenue of 87.31B with 14.11% growth. That makes KBIO LABS the 25,463rd largest company in the world by revenue and 1,499th in South Korea.

• Revenue (ttm): 92.08B
• Revenue Growth: +57.61%
• P/S Ratio: 0.18
• Revenue / Employee: 2.42B
• Employees: 38
• Market Cap: 16.85B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• ICT Business Division 50.82B 58.2%
• Bio Distribution Division 36.49B 41.8%

By Geography

Chart

• South Korea 73.35B 84.0%
• Overseas 13.97B 16.0%

Fiscal year ended Dec 31, 2025 See the full KBIO LABS breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.31B	10.80B	14.11%
Dec 31, 2024	76.51B	49.19B	180.02%
Dec 31, 2023	27.32B	-3.80B	-12.22%
Dec 31, 2022	31.13B	22.41B	256.90%
Dec 31, 2021	8.72B	3.01B	52.80%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error